Related Experiment Video

Updated: Apr 26, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Molecular targeted α-particle therapy for oncologic applications

Thaddeus J Wadas1, Darpan N Pandya, Kiran Kumar Solingapuram Sai

  • 11 Department of Radiology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157.

AJR. American Journal of Roentgenology
|July 24, 2014
PubMed
Abstract

Insights

Targeted alpha-particle therapy offers a new era in cancer treatment by precisely targeting tumors. This approach minimizes harm to normal tissues, improving patient outcomes in oncology.

Area of Science:

  • Oncology
  • Radiochemistry
  • Molecular Biology

Background:

  • Traditional cancer therapies often cause significant damage to healthy tissues.
  • Targeted therapies using antibodies specific to tumor biomarkers represent a promising advancement.

Purpose of the Study:

  • To highlight recent developments in alpha-particle therapy.
  • To demonstrate the potential of targeting tumor-restricted molecular biomarkers with alpha-particle emitters.

Main Methods:

  • Review of recent advancements in alpha-particle therapy.
  • Exploration of antibody-targeted delivery systems for alpha-particle emitters.

Main Results:

  • Development of alpha-particle therapies that precisely target cancer cells.
  • Successful application of tumor-restricted biomarkers for targeted delivery.

Conclusions:

  • Alpha-particle therapy, when targeted, offers a potent and precise treatment modality.
  • Recent progress enables the exploitation of alpha-particle therapy for improved cancer treatment outcomes.
Keywords:
213Bi223Ra225Acmolecular radiotherapynuclear medicineradioimmunotherapyα-particle therapy

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

7.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

10.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161